A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia
- 1 February 2000
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 1 (1), 41-49
- https://doi.org/10.1016/s1389-9457(99)00006-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lack of Residual Sedation Following Middle-of-the-Night Zaleplon Administration in Sleep Maintenance InsomniaClinical Neuropharmacology, 2000
- A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakeningBritish Journal of Clinical Pharmacology, 1999
- Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound EffectsThe Primary Care Companion For CNS Disorders, 1999
- Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*Clinical Pharmacology & Therapeutics, 1998
- Efficacy and Tolerability of 14-Day Administration of Zaleplon 5mg and 10mg for the Treatment of Primary InsomniaClinical Drug Investigation, 1998
- A Review of the Preclinical Development of Zaleplon, a Novel Non‐Benzodiazepine Hypnotic for the Treatment of InsomniaCNS Drug Reviews, 1997
- Zolpidem and Rebound Insomnia - A Double-Blind, Controlled Polysomnographic Study in Chronic Insomniac PatientsPharmacopsychiatry, 1994
- Early Morning Insomnia with Rapidly Eliminated BenzodiazepinesScience, 1983
- Benzodiazepine hypnotics remain effective for 24 weeks.BMJ, 1982
- Long‐Term Hypnotic Efficacy and Safety of Triazolam and FlurazepamThe Journal of Clinical Pharmacology, 1978